Douglas L Braunstein Insider Trading $EGRX EAGLE PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas L Braunstein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas L Braunstein. Douglas L Braunstein is Chief Financial Officer in JPMORGAN CHASE & CO ($JPM) and Director in USA TECHNOLOGIES INC ($USAT) and Director in EAGLE PHARMACEUTICALS, INC. ($EGRX) and Director in Corindus Vascular Robotics, Inc. ($CVRS).
Douglas L Braunstein in EAGLE PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas L Braunstein: Director
Holdings: 911,777 shares
Current Value: $63,313,795
Latest Transaction: May 13 2019
$EGRX Market Capitalization: $1.09B
$EGRX Previous Close: $69.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Douglas L Braunstein in EAGLE PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, USAT, CVRS, EGRX, JPM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Sell | S | 56.14 | 100,000 | 5,614,000 | 811,777 | 911.8 K to 811.8 K (-10.97 %) |
| May 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Sell | S | 56.14 | 100,000 | 5,614,000 | 811,777 | 911.8 K to 811.8 K (-10.97 %) |
| May 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Sell | S | 57.95 | 59,223 | 3,431,973 | 911,777 | 971 K to 911.8 K (-6.10 %) |
| May 13 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Sell | S | 57.95 | 59,223 | 3,431,973 | 911,777 | 971 K to 911.8 K (-6.10 %) |
| Jan 25 2019 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 42.40 | 10,000 | 424,000 | 10,000 | |
| Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 59.14 | 10,000 | 591,400 | 10,000 | |
| Aug 11 2017 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Buy | P | 50.09 | 1,584 | 79,338 | 971,000 | 969.4 K to 971 K (+0.16 %) |
| Aug 11 2017 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Buy | P | 49.21 | 15,206 | 748,258 | 969,416 | 954.2 K to 969.4 K (+1.59 %) |
| Aug 11 2017 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Buy | P | 48.06 | 3,610 | 173,490 | 954,210 | 950.6 K to 954.2 K (+0.38 %) |
| Jan 06 2017 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 84.92 | 10,000 | 849,200 | 10,000 | |
| Jul 06 2016 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 41.01 | 10,000 | 410,100 | 10,000 |
Page: 1